Skip to content

A Pilot Study of Working Women and Breast Cancer

A Pilot Study of Working Women and Breast Cancer

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01914614
Enrollment
22
Registered
2013-08-02
Start date
2013-11-30
Completion date
2015-04-30
Last updated
2015-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Keywords

Breast Cancer, Working Women

Brief summary

The purpose of this research is to better understand the relationship between employment and breast cancer. Research is being conducted to understand how workplace factors influence breast cancer patients' ability to adhere to recommended cancer treatment and effectively recover from cancer. Investigators hope to use the findings from the study to help working breast cancer survivors make informed decisions about treatment and employment in collaboration with their employers and healthcare providers.

Detailed description

Patients enrolled will be interviewed three times over a six month period. They will be asked questions about their experiences in managing their cancer while taking care of their job responsibilities. Patients will be asked to complete a survey that asks questions about their breast cancer treatment, their job, and how they manage their responsibilities while undergoing cancer treatment. The first initial meeting will be conducted at a time and location that is convenient for the patient. This meeting should last about an hour to an hour and a half. Three and six months after the initial interview, study participants will be asked to complete a follow-up survey by either telephone or Internet/Web, depending on their preference. These telephone surveys will last between 15-30 minutes.

Interventions

None listed

Sponsors

National Institute on Drug Abuse (NIDA)
CollaboratorNIH
Robin Vanderpool
Lead SponsorOTHER

Study design

Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Women age 18-65 * Working at least 20 hours per week * Currently patients of the University of Kentucky Markey Cancer Center * Are able to read, write, and communicate in English * Have reliable telephone or Internet/Web access in or outside the home

Exclusion criteria

* Self-employed * Unemployed * Cognitively impaired

Design outcomes

Primary

MeasureTime frameDescription
Guideline concordant breast cancer treatment as defined by National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology and oncologist assessments.6 monthsDifferences in receipt of guideline-concordant breast cancer treatment between working poor and working non-poor survivors as explained by variations in occupation and work organization factors associated with each group of women. Guideline-concordant treatment will be informed by National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology and oncologist assessments.

Secondary

MeasureTime frameDescription
Breast cancer treatment adherence, including completion of prescribed chemotherapy regimens, prescribed radiation treatment regimen, and/or surgical follow-up appointments.6 monthsDifferences in breast cancer treatment adherence rates between working poor and non-poor survivors as explained by variations in occupation and work organization factors associated with each group of women.
Satisfaction with breast cancer treatment decision-making6 monthsDifferences in satisfaction with breast cancer treatment decision-making between working poor and working non-poor survivors as explained by variations in occupation and work organization factors associated with each group of women.
Quality of life6 monthsDifferences in quality of life measures between working poor and working non-poor survivors explained by variations in occupation and work organization factors associated with each group of women.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026